This reduction is accompanied by an upregulation in the activity of ECM proteases such as tPA and MMP-9 and a modulation in the expression of ECM proteases and inhibitors such as Adamts4 and Timp1. Similar results were seen in brain tissue from stroke patients. This evidence concerns the gene TIMP1 and stroke disorder.